Myriad Genetics Inc MYGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:42 PM EDT
25.27quote price arrow down-0.84 (-3.22%)
Volume
484,160
52 week range
10.54 - 33.97

...

Loading . . .
  • Open24.99
  • Day High26.43
  • Day Low24.54
  • Prev Close26.11
  • 52 Week High33.97
  • 52 Week High Date04/06/21
  • 52 Week Low10.54
  • 52 Week Low Date06/25/20

Key Stats

  • Market Cap1.947B
  • Shares Out77.05M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta1.61
  • YTD % Change29.36

KEY STATS

  • Open24.99
  • Day High26.43
  • Day Low24.54
  • Prev Close26.11
  • 52 Week High33.97
  • 52 Week High Date04/06/21
  • 52 Week Low10.54
  • 52 Week Low Date06/25/20
  • Market Cap1.947B
  • Shares Out77.05M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta1.61
  • YTD % Change29.36

RATIOS/PROFITABILITY

  • EPS (TTM)-2.32
  • P/E (TTM)-10.89
  • Fwd P/E (NTM)-91.56
  • EBITDA (MRQ)-130.90M
  • ROE (MRQ)-18.31%
  • Revenue (MRQ)566.10M
  • Gross Margin (MRQ)68.49%
  • Net Margin (MRQ)-29.82%
  • Debt To Equity (MRQ)17.60%

EVENTS

  • Earnings Date08/11/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Myriad Genetics Inc

There is no recent news for this security.

Profile

MORE
Myriad Genetics, Inc. is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The Company operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to drug therapy and guide a...
S. Louise Phanstiel CPA
Chairman
Paul Diaz J.D.
President
R. Bryan Riggsbee CPA
Chief Financial Officer
Paul Parkinson
Executive Vice President
Benjamin Jackson J.D.
Executive Vice President
Address
320 S Wakara Way
Salt Lake City, UT
84108-1214
United States

Top Peers

SYMBOLLASTCHG%CHG
LMNX
Luminex Corp
36.62-0.15-0.42%
CHRS
Coherus BioSciences Inc
14.01-0.27-1.89%
ACAD
ACADIA Pharmaceuticals Inc
20.84-0.18-0.86%
BLUE
bluebird bio Inc
29.38+0.98+3.45%